Hiv 0

7/29/2019 Hiv 0

1/4

Summary

The HIV/AIDS epidemic

continues to be a major global

health challenge, but with U.S.

support and leadership, an

AIDS-free generation is within

reach.

HIV/AIDS impacts the overall

development in many of the

most vulnerable countries

because it undermines efforts

to reduce poverty, improve

access to education and

healthcare, address gender

inequalities and maintain

national security.

The U.S. is the largest funder of

HIV/AIDS programs worldwide

through support for the

Presidents Emergency Plan for

AIDS Relief (PEPFAR) and the

Global Fund to Fight AIDS,

Tuberculosis and Malaria

(Global Fund).1

HIV/AIDS

Overview

In 2011, approximately 34 million people worldwide, including 3.4million children under 15, were living with HIV/AIDS. However, the

number of new HIV infections and deaths from the disease are on the

decline in many of the hardest-hit countries.2

In 2011, 1.7 million people died of AIDS-related illnesses and 2.5

million people were newly infected with HIV.3 In fact, 39 countries have

seen new infections among adults decrease by more than 25 percent

between 2001 and 2011, and deaths from AIDS have fallen by one-

third in the past 6 years.4

The HIV/AIDS pandemic disproportionately affects sub-Saharan Africa,

where almost three out of every four new infections occur.5

Millions of HIV-infected individuals lack the treatment services they

need to survive and thrive. The number of children accessing

treatment is especially troubling, with only 28 percent of eligible

children on treatment compared to 54 percent of eligible adults.6

The majority of those living with HIV do not know they are infected. 7

Women represent more than half of all current cases of HIV. Women

also often have less power in relationships and during sexual

encounters, leaving them vulnerable to coercion and gender-based

violence. HIV/AIDS is the leading cause of death among women of

reproductive age.8

Stigma, discrimination, legal barriers and the violation of human rights

pose major obstacles for key populations including men who have

sex with men, sex workers and people who use drugs to access HIV

prevention, treatment and care services in many countries around the

world.

PEPFAR is the largest commitment by a nation to combat a single

disease internationally, both programmatically and scientifically.

Additionally, the U.S. is responsible for 72 percent of global spending

on HIV/AIDS research and development.9

The Global Fund was created in 2002 to raise and disburse large sums

of money around the world to prevent and treat AIDS, tuberculosis andmalaria, diseases that together kill 5 million people every year. An

innovative public-private partnership, the Global Fund leverages $2 for

every $1 invested by the U.S. government while maximizing impact by

working in close coordination with PEPFAR and other U.S. programs.

James Pursey

Global Health Briefing Book 2013 | 7

7/29/2019 Hiv 0

2/4

Making Progress

As of the end of FY2012, U.S.

assistance directly supported

more than 5.1 million patients on

life-saving antiretroviral

treatment, and more than 46.5

million people with counseling and

testing programs.10

PEPFAR provided resources and

funding for the prevention of

mother-to-child HIV transmission

for more than 11 million HIV-

positive pregnant women, allowing

more than 230,000 infants to be

born HIV-free in FY2012. Globally over 57 percent of women received the necessary treatment and services

to reduce transmission from mother to child, up from 15 percent in 2005.11

As of December 2012, the Global Fund had provided HIV/AIDS treatment to 4.2 million people, as well as

services to 1.7 million pregnant women. On average, the Global Fund saves 100,000 lives each month with

its work on HIV, tuberculosis and malaria.

Recent scientific advances have reinforced the fact that putting HIV-positive individuals on treatment is not only

good for their own health, but also reduces the likelihood of transmission to others.

PEPFAR plays a fundamental role in reaching key populations with targeted services and creating an enabling

environment for working with stigmatized groups in both generalized and concentrated epidemics.

To ensure that countries are able to sustain and build on progress to date, PEPFAR programs continue to invest in

building strong health and community systems that increase national capacity to implement country-led HIV/AIDS

programs.

PEPFAR has begun to transition from an emergency response to one of long-term sustainability through

partnerships and country ownership. U.S. investment has been leveraged with other bilateral and multilateral

partners to create a truly global response.

U.S. Response and Strategy

Since President George W. Bushs announcement of PEPFAR in 2003, the U.S. has invested more than $40 billion in

the global AIDS response. The program was most recently reauthorized through the Tom Lantos and Henry J. Hyde

United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act of 2008.

Implemented through the Office of the Global AIDS Coordinator (OGAC) in the Department of State, PEPFAR is a

multiagency effort supporting HIV/AIDS programs mainly through USAID and the Centers for Disease Control and

Prevention, with additional programming through the Department of Defense, the Department of Health and HumanServices and the Peace Corps. The program works closely with other major bilateral and multilateral donors such as

the Global Fund.12

Scientific advances since the beginning of PEPFAR have improved how we respond to the global HIV/AIDS epidemic,

and in turn have made U.S.-funded programming more efficient and effective. The PEPFAR program now has a clear

plan how the U.S. government is going to lead the world towards the end of AIDS in the recent Blueprint Towards an

AIDS-Free Generation. The Blueprint has a simple goal: make smart investments based on sound science with a

shared global responsibility in order to achieve an AIDS-free generation.

Source: AIDSInfo


7/29/2019 Hiv 0

3/4

Recommendations

Congress should maintain strong funding levels for the PEPFAR program. We recognize that these are

challenging economic times. However, U.S.-funded global HIV/AIDS programs have shown a consistent return on

investment measured in lives saved, costs avoided through infections prevented and the generation of goodwill

among global partners. Strong support from Congress, including policies that support the effectiveness of HIV/

AIDS programming, is critical to advancing the global AIDS response.

Congress should continue to support the Global Fund. Multilateral funding complements bilateral funding by

leveraging investments from other donors, helping build country-level commitment and strengthening capacity at

all levels to deliver programs. U.S. leadership has been and remains the most important leveraging tool available

to the Global Fund. In the lead up to the Fourth Replenishment of the Global Fund, scheduled for fall 2013, it is

critically important for the U.S. government to signal to the international community its continued strong support by

providing robust funding for the Global Fund in FY2014.

Support scientific advances towards the end of HIV/AIDS. Even with amazing strides toward ending the global

AIDS crisis, many undiscovered breakthroughs remain. A vaccine and a cure are on the horizon. New

technologies and treatments could be game changers. Ten years of global HIV/AIDS programming experience will

pave the way towards an AIDS-free generation if we can harness lessons learned. U.S. support for HIV/AIDSresearch is critical, not just for those suffering from and at risk for HIV/AIDS around the world, but also for the more

than 1 million people living with HIV in the United States.

Source: 2012 Country Progress Reports (www.unaidsorg


7/29/2019 Hiv 0

4/4

Contributors

Elizabeth Glaser Pediatric AIDS Foundation

Katie Lapides Coester

[email protected]

International HIV/AIDS Alliance

Marielle Hart

[email protected]

International AIDS Vaccine Initiative (IAVI)

Jennie Aylward

[email protected]

1 Neglected disease R&D: A five-year review, G-FINDER, 2012. Pg. 28.2 Report on the Global AIDS Epidemic, UNAIDS, 2012. Pg. 8.3 Ibid. Pg. 8.4 Ibid. Pg. 11.5

Ibid. Pg. 11.6 Ibid. Pg. 47.7 Progress Report 2011: Global HIV/AIDS Response, WHO/UNAIDS/UNICEF, 2011.8 Women and Health: Today's Evidence Tomorrow's Agenda, The World Health Organization, 2009.9 Neglected disease R&D: A five-year review, G-FINDER, 2012. Pg. 28.10 World AIDS Day 2012 Update, PEPFAR. http://www.pepfar.gov/funding/results/index.htm.11 On the Road to an AIDS-Free Generation, Dipnote. http://blogs.state.gov/index.php/site/entry/on_the_road_to_aids_free_generation.12 Report on the Global AIDS Epidemic, UNAIDS, 2012. Pg. 11.


Documents

Hiv 0